{"schema_version":"1","generated_at":"2026-11-04T05:30:25.228Z","data_as_of":null,"url":"https://www.findmykol.com/kol/joseph-jurcic","json_url":"https://www.findmykol.com/kol/joseph-jurcic/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"joseph-jurcic","name":"Joseph Jurcic","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"NewYork–Presbyterian Hospital","institution_url":"https://www.findmykol.com/institution/weill-cornell-medicine","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1295838076","orcid":"0000-0002-1671-9998","openalex":"A5055703943"},"summary":"Joseph Jurcic is a Hematology physician affiliated with NewYork–Presbyterian Hospital. OpenAlex indexes 245 publications with 11,001 citations (h-index 45); ClinicalTrials.gov lists 9 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":245,"cited_by_count":11001,"h_index":45,"latest_activity_year":2026,"source":"works"},"trials":{"count":9,"shown":3,"withheld":6,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06351306","title":"DEC-C and Thioguanine for R/R AML","phase":"PHASE2","status":"WITHDRAWN","role":"Overall official","sponsor":"Columbia University","source_url":"https://clinicaltrials.gov/study/NCT06351306","trial_url":"https://www.findmykol.com/trial/NCT06351306"},{"nct":"NCT05524857","title":"Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP)","phase":"PHASE1","status":"TERMINATED","role":"Overall official","sponsor":"Joseph Jurcic","source_url":"https://clinicaltrials.gov/study/NCT05524857","trial_url":"https://www.findmykol.com/trial/NCT05524857"},{"nct":"NCT03705858","title":"Actinium-225-Lintuzumab in Patients With Acute Myeloid Leukemia","phase":"PHASE1","status":"WITHDRAWN","role":"Overall official","sponsor":"Joseph Jurcic","source_url":"https://clinicaltrials.gov/study/NCT03705858","trial_url":"https://www.findmykol.com/trial/NCT03705858"}],"source":"trials"},"payments":{"company_count":14,"program_years":{"first":2021,"last":null},"rows_total":46,"shown":3,"withheld":43,"rows":[{"payer":"Blueprint Medicines","program_year":2025,"amount_usd":117235.26,"payment_count":11,"source_url":"https://openpaymentsdata.cms.gov/search?query=1295838076"},{"payer":"Sumitomo Pharma","program_year":2025,"amount_usd":45907.41,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1295838076"},{"payer":"Sanofi","program_year":2025,"amount_usd":43562.29,"payment_count":9,"source_url":"https://openpaymentsdata.cms.gov/search?query=1295838076"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1295838076","source":"payments"},"funding":{"award_count":2,"fiscal_years":{"first":2008,"last":2026},"rows_total":5,"shown":3,"withheld":2,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"P30CA013696","title":"Protocol Review and Monitoring System","fiscal_year":2026,"amount_usd":"448660","organization":"COLUMBIA UNIVERSITY HEALTH SCIENCES","source_url":"https://reporter.nih.gov/quickSearch/P30CA013696"},{"project":"P30CA013696","title":"Protocol Review and Monitoring System","fiscal_year":2025,"amount_usd":"453660","organization":"COLUMBIA UNIVERSITY HEALTH SCIENCES","source_url":"https://reporter.nih.gov/quickSearch/P30CA013696"},{"project":"P50CA086438","title":"Developmental Research Program","fiscal_year":2010,"amount_usd":"159080","organization":"SLOAN-KETTERING INST CAN RESEARCH","source_url":"https://reporter.nih.gov/quickSearch/P50CA086438"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.22.01794","status":"verified"},{"title":"Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML","year":2023,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2022009411","status":"verified"},{"title":"Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.22.02721","status":"verified"},{"title":"A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies","year":2023,"journal":"Cancer Discovery","source_url":"https://doi.org/10.1158/2159-8290.cd-22-1020","status":"verified"},{"title":"Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML","year":2022,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2022008806","status":"verified"}],"source":"works"},"contact":{"address_1":"622 W 168TH ST","city":"New York","state":"NY","zip":"100323720","phone":"646-227-3275","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1295838076","source":"identity"},"similar":[{"name":"Melana Yuzefpolskaya","slug":"melana-yuzefpolskaya","institution":"NewYork–Presbyterian Hospital","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/melana-yuzefpolskaya","json_url":"https://www.findmykol.com/kol/melana-yuzefpolskaya/profile.json"},{"name":"Kevin Clerkin","slug":"kevin-clerkin","institution":"NewYork–Presbyterian Hospital","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/kevin-clerkin","json_url":"https://www.findmykol.com/kol/kevin-clerkin/profile.json"},{"name":"Brandon Swed","slug":"brandon-swed","institution":"NewYork–Presbyterian Hospital","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/brandon-swed","json_url":"https://www.findmykol.com/kol/brandon-swed/profile.json"},{"name":"Lawrence Lenke","slug":"lawrence-lenke","institution":"NewYork–Presbyterian Hospital","specialty":"Orthopaedic Surgery","url":"https://www.findmykol.com/kol/lawrence-lenke","json_url":"https://www.findmykol.com/kol/lawrence-lenke/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jaroslaw Maciejewski","slug":"jaroslaw-maciejewski","institution":"Cleveland Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/jaroslaw-maciejewski","json_url":"https://www.findmykol.com/kol/jaroslaw-maciejewski/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":6,"payments":43,"funding":2,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-04-25","provider_certified":"2023-04-25","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}